文献速递浆细胞疾病

筛查未定意义的单克隆丙种球蛋白病是禁忌的

Screening for monoclonal gammopathy of undetermined significance is contraindicated.
PubMed 文献 · Br J Haematol · 2025-05-22

文章反对筛查未定意义的单克隆丙种球蛋白病(MGUS)。多发性骨髓瘤发病率约1.8/10万,50岁以上成人中约3%-5%被诊断为MGUS。若以血清游离轻链比值异常为标准,每1万人中300-500人被贴上该癌前病变标签,但此类诊断96%不正确。采用严格标准时仅约10人/1万有MGUS,10年内仅1人进展为多发性骨髓瘤,且该1人也不能从“早期”诊断中获益,故筛查只有害无益。

要点

  • 多发性骨髓瘤发病率约1.8/10万。
  • 50岁以上成人中约3%-5%被诊断为MGUS。
  • 基于轻链比值异常的MGUS诊断96%不正确,严格标准下仅约10人/1万有MGUS。

核心结论

  • 筛查未定意义的单克隆丙种球蛋白病只有害处而无益处。

研究设计与样本

  • 原文未报告研究设计。

主要发现

  • 多发性骨髓瘤发病率约1.8/100 000。
  • 50岁以上成人中约3%-5%被诊断为未定意义的单克隆丙种球蛋白病(MGUS)。
  • 以血清游离轻链比值异常为诊断标准时,每10 000人中300-500人被贴上该癌前病变标签;此类基于轻链比值异常的诊断96%不正确。
  • 采用要求存在单克隆免疫球蛋白的严格标准时,每10 000人中仅约10人可能有MGUS,10年内仅1人可能进展为多发性骨髓瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Incidence of multiple myeloma is about 1.8/100 000. About 3%-5% of adults >50 years of age are diagnosed with monoclonal gammopathy of undetermined significance (MGUS). The prevalence is higher if diagnosis is based on an abnormal ratio of serum free light chains. 300-500 people/10 000 get labelled with a diagnosis of this pre-malignant disorder by using faulty criterion of abnormal light chain ratio. Diagnoses based on an abnormal light chain ratio are incorrect in 96% of instances. However, a large number of people are subjected to psychological trauma and financial toxicity by subjecting them to repeated and invasive testing. If strict criteria requiring the presence of a monoclonal immunoglobulin were used, only about 10 people/10 000 may have MGUS and only one person may progress to multiple myeloma in 10 years. Even that one person gains no benefit from an 'early' diagnosis. Thus, there is only harm and no benefit from screening for MGUS.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Singh G. Screening for monoclonal gammopathy of undetermined significance is contraindicated. Br J Haematol. 2025. PMID: 40400390. doi:10.1111/bjh.20175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。